Europe Mice Model Market (2025-2030)
The Europe Mice Model Market was valued at $297.9 Million in 2025 and projected to reach to $456.1 Million by 2030, representing a compound annual growth rate of 8.9%. Europe's mice model market is poised for sustained growth through 2030, driven by increasing investment in biomedical research, rising pharmaceutical development activities, and the region's commitment to 3Rs principles (Replacement, Reduction, Refinement).
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe Mice Model Market Trends and Insights
- This 8.9% compound annual growth rate reflects Europe's strong commitment to biomedical research and pharmaceutical development.
- Europe maintains a robust infrastructure for preclinical testing, with leading research institutions and contract research organizations driving demand for high-quality mouse models across the region. The European mice model market benefits from stringent regulatory frameworks that mandate comprehensive preclinical testing before clinical trials.
- Europe's emphasis on ethical research practices and the 3Rs principle (Replace, Reduce, Refine) has spurred innovation in mouse model development and breeding technologies.
- Between 2025 and 2030, Europe is expected to see increased adoption of genetically modified and disease-specific mouse models, particularly in oncology, neurology, and immunology research. Key drivers of growth in Europe include rising R&D investments by pharmaceutical companies, expansion of academic research programs, and growing collaboration between European research institutions.
- Europe's regulatory environment continues to support the mice model market through requirements for animal testing in drug development, ensuring sustained demand throughout the forecast period..
Key Market Statistics
- CAGR (2025-2030) 8.9% CAGR
- Market Size, 2025 ~USD 297.9 Million
- Forecast, 2030 ~USD 456.1 Million
- Geography Europe
Europe Mice Model Market Overview
Market Valuation & Growth :
Europe's mice model market is valued at $297.9 million in 2025, with a projected expansion to $456.1 million by 2030, representing a steady 8.9% CAGR that underscores the region's commitment to advanced biomedical research.
Leading Research Infrastructure :
Europe hosts world-class research institutions and contract research organizations (CROs) that drive demand for preclinical testing models, positioning the region as a hub for pharmaceutical development and regulatory compliance.
Regulatory Excellence & Standards :
Stringent EU regulations and ethical guidelines for animal research ensure high-quality mice model production and utilization, supporting Europe's reputation for rigorous preclinical validation in drug discovery.
Key Market Contributors :
Germany ($132.2M), UK ($143.1M), and France ($75.3M) are the dominant markets within Europe, collectively driving innovation in genetic models and specialized breeding facilities for pharmaceutical and biotechnology sectors.
Europe Mice Model Market Dynamics
- The market benefits from established CRO networks, advanced breeding facilities, and strong regulatory frameworks that ensure compliance with EU standards. Key growth catalysts include expanding oncology and neurology research programs, growing adoption of genetically modified mouse models, and increased collaboration between academic institutions and pharmaceutical companies.
- Europe's focus on personalized medicine and translational research will continue to elevate demand for specialized mice models, supporting market expansion at a 8.9% CAGR through the forecast period..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Europe's mice model market will grow from $297.9M (2025) to $456.1M (2030) at an 8.9% CAGR
- Europe's stringent regulatory requirements and 3Rs ethical framework drive sustained demand for specialized mouse models
- Genetically modified and disease-specific mouse models are experiencing accelerated adoption across European research institutions
- Collaborative R&D initiatives and pharmaceutical investments position Europe as a leading market for preclinical research models
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area, End User |
Europe Mice Model Market Report Segmentation
6 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
By End User
- Academic & Research Institutes
- Contract Research Organizations (Cros) & Contract Development And Manufacturing Organizations (Cdmos)
- Pharmaceutical & Biotechnology Companies
Target Audience
- Pharmaceutical Companies : European and global pharma firms require comprehensive market data to optimize preclinical research budgets, select CRO partners, and accelerate drug development timelines within the region.
- Contract Research Organizations (CROs) : CROs operating in Europe need market intelligence to benchmark services, identify growth opportunities, and expand their mice model offerings to meet evolving client demands.
- Biotechnology & Life Sciences Firms : Biotech companies conducting research in Europe require detailed market insights to source quality mice models, understand pricing dynamics, and plan R&D investments effectively.
- Research Institutions & Universities : Academic research centers across Europe need market data to secure funding, justify procurement decisions, and stay informed about available mice model resources and suppliers.
- Investors & Business Development : Investment firms and corporate development teams evaluating opportunities in Europe's biomedical research sector require market sizing, growth forecasts, and competitive intelligence.
Key Companies in the Europe Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 132.2 Million |
| UK | USD 143.1 Million |
| France | USD 75.3 Million |
| Italy | USD 47.1 Million |
| Spain | USD 31.7 Million |
| Rest Of Europe | USD 103.9 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Segmentation : Gain detailed insights into Europe's mice model market with country-level breakdowns for Germany, UK, France, Italy, Spain, and Rest of Europe, enabling targeted market entry and expansion strategies.
- Competitive Landscape Analysis : Understand the competitive positioning of European CROs, breeding facilities, and suppliers operating within the region's regulated environment and ethical frameworks.
- Growth Opportunity Identification : Identify high-growth segments within Europe's mice model market, including specialized genetic models, disease-specific strains, and emerging therapeutic areas driving demand.
- Regulatory & Compliance Insights : Navigate Europe's complex regulatory landscape, including EU animal welfare directives and ethical guidelines that impact mice model production, sourcing, and utilization strategies.
- Strategic Partnership Opportunities : Discover collaboration potential with leading European research institutions, pharmaceutical companies, and CROs to accelerate market penetration and innovation in preclinical research.
Frequently asked questions
What is the current size of Europe's mice model market?
Europe's mice model market was valued at $297.9 million in 2025 and is projected to reach $456.1 million by 2030.
What is the expected growth rate for Europe's mice model market?
Europe's mice model market is expected to grow at a compound annual growth rate (CAGR) of 8.9% from 2025 to 2030.
What regulatory factors influence Europe's mice model market?
Europe's stringent regulatory frameworks, including the 3Rs principle (Replace, Reduce, Refine) and mandatory preclinical testing requirements, significantly influence market demand and innovation in mouse model development.
Which therapeutic areas drive demand for mice models in Europe?
Oncology, neurology, and immunology research represent key therapeutic areas driving demand for specialized and genetically modified mouse models across Europe.
What are the main growth drivers for Europe's mice model market?
Rising pharmaceutical R&D investments, expansion of academic research programs, increased collaboration between European institutions, and regulatory mandates for preclinical testing are primary growth drivers in Europe.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
- Rest Of Latin America Mice Model Market
- Ksa Mice Model Market
- Other GCC Countries Mice Model Market
- UAE Mice Model Market
- GCC Countries Mice Model Market
- Rest Of The Middle East Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report